Adynxx, Inc. Adynxx, Inc.

Adynxx, Inc.

ADYX

Rank in Stocks #35066
Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating... Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating and commercializing novel transcription factor decoy technologies to combat pain and inflammatory conditions. Central to its efforts is the AYX platform of transcription factor decoys, which includes brivoligide, currently progressing through Phase II clinical development for reducing post-surgical discomfort. Additionally, AYX2 is a pre-clinical candidate being explored for its potential in treating localized chronic pain. Established in 2007, the company's corporate headquarters are situated in San Francisco, California.
Share Price
$0.0001
Last synced: 2026-11-13
Market Cap
$580.79
Change (1 day)
0.00%
Change (1 year)
0.00%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for Adynxx, Inc. (ADYX)
EPS as of September 2019 TTM: $-3.79
According to Adynxx, Inc.'s latest financial reports, its current EPS (TTM) is $-3.79. At the end of 2018 the company had an EPS of $-10.26, an increase over its 2017 EPS of $-35.94.
EPS history for Adynxx, Inc. from 2000 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-3.79 -63.06%
2018 $-10.26 -71.45%
2017 $-35.94 -40.69%
2016 $-60.60 -10.47%
2015 $-67.69 -35.14%
2014 $-104.36 -44.61%
2013 $-188.40 245.05%
2012 $-54.60 -68.90%
2011 $-175.55 236.75%
2010 $-52.13 98.59%
2009 $-26.25 -76.56%
2008 $-112.01 -28.76%
2007 $-157.22 -8.06%
2006 $-171.01 60.48%
2005 $-106.56 82.68%
2004 $-58.33 11.00%
2003 $-52.55 185.91%
2002 $-18.38 98.27%
2001 $-9.27 80.35%
2000 $-5.14 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$-0.89 -76.52%
US
$15.66 -513.19%
US
$-7.07 86.54%
US
$-5.29 39.58%
AU
$12.73 -435.94%
BE

Questions about Adynxx, Inc.'s earnings per share (EPS)

What is Adynxx, Inc.'s earnings per share (EPS)?

Adynxx, Inc.'s earnings per share (EPS) over the last twelve months is $-3.79, as of Sep 2019.

What was Adynxx, Inc.'s earnings per share (EPS) in 2018?

In 2018, Adynxx, Inc.'s earnings per share (EPS) was $-10.26, compared with $-35.94 in 2017.

How has Adynxx, Inc.'s earnings per share (EPS) changed since 2013?

From 2013 to 2018, Adynxx, Inc.'s earnings per share (EPS) was highest in 2018 ($-10.26) and lowest in 2013 ($-188.40).

How does Adynxx, Inc.'s earnings per share (EPS) compare with similar companies?

Adynxx, Inc.'s earnings per share (EPS) ($-3.79) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.